BioCatalyst

Combination Product: FDC of spironolactone and ER torsemide, Combination Product: Stabilized doses of loop diuretic and finerenone — catalyst calendar

1 verified catalyst event(s) referencing Combination Product: FDC of spironolactone and ER torsemide, Combination Product: Stabilized doses of loop diuretic and finerenone, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-07 (month)
in 9d
ESTIMATED
 READOUT
A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combina
Phase 3 · Hypertension (HTN)
 Sarfez Pharmaceuticals, Inc. Combination Product: FDC of spironolacto ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.